Bayer eyes German launch of stroke drug despite spending cuts in the country
Bayer said Tuesday it still plans to launch its new stroke drug in “every country possible,” including its home country of Germany, in spite of the drugmaker’s objections to the country’s new healthcare spending bill ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.